RELMADA THERAPEUTICS, INC. - RLMD
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Chief Executive Officer | A | A | 1,198,000.0 | 0.0 | 0.0 | 1,198,000.0 | View | |
| Dec 16, 2025 | Chief Executive Officer | P | A | 27,500.0 | 4.12 | 113,300.0 | 1,300,000.0 | View | |
| Dec 16, 2025 | Chief Financial Officer | A | A | 828,000.0 | 0.0 | 0.0 | 828,000.0 | View | |
| Dec 16, 2025 | Chief Financial Officer | P | A | 11,665.0 | 4.12 | 48,059.8 | 800,000.0 | View | |
| Dec 16, 2025 | CA and CO | A | A | 828,000.0 | 0.0 | 0.0 | 828,000.0 | View | |
| Dec 16, 2025 | — | A | A | 164,000.0 | 0.0 | 0.0 | 164,000.0 | View | |
| Dec 16, 2025 | — | A | A | 164,000.0 | 0.0 | 0.0 | 164,000.0 | View | |
| Dec 16, 2025 | COO | A | A | 828,000.0 | 0.0 | 0.0 | 828,000.0 | View | |
| Dec 16, 2025 | — | A | A | 164,000.0 | 0.0 | 0.0 | 164,000.0 | View | |
| Nov 06, 2025 | Chief Financial Officer | P | A | 500,000.0 | 2.2 | 1,100,000.0 | 788,335.0 | View | |
| Nov 06, 2025 | CAO and COO | P | A | 136,000.0 | 2.2 | 299,200.0 | 403,931.0 | View | |
| Nov 06, 2025 | Chief Executive Officer | P | A | 272,500.0 | 2.2 | 599,500.0 | 1,272,500.0 | View | |
| Nov 06, 2025 | Chief Operating Officer | P | A | 90,000.0 | 2.2 | 198,000.0 | 502,295.0 | View |